Targeting the negative regulators, Dusp1 and Ptprs may prove not to be a viable treatment for aging individuals with pneumococcal infections as they are needed to restrain excessive inflammation, and instead, the focus should be on reducing the root cause of excessive inflammation. The gene discussed is DUSP1; the disease is pneumococcal infection.